Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1

Interventions

Cytarabine 54Etoposide 22Daunorubicin 20Filgrastim 18Busulfan 15Idarubicin 14Cyclophosphamide 14fludarabine phosphate 13Peripheral Blood Stem Cell Transplantation 12Mitoxantrone 12tipifarnib 11Gemtuzumab 10Flow Cytometry 10Antilymphocyte Serum 10Cyclosporine 9sargramostim 8Gene Expression Profiling 8Clofarabine 8Radiotherapy 7Methotrexate 7Topotecan 6valspodar 5aldesleukin 5Azacitidine 5alvocidib 4Observation 4Methylprednisolone 4Melphalan 4Granulocyte Colony-Stimulating Factor 4Arsenic Trioxide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Megakaryoblastic, Acute × choline magnesium trisalicylate × Clear all
NCT02144675 2021-08-24

Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia

Rutgers, The State University of New Jersey

Phase 2 Completed
27 enrolled 9 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡